DeepMed Research

THE UNIVERSITY OF QUEENSLAND

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1909-01-01

Employees: 5K

Market Cap: -

Website: http://www.uq.edu.au

Clinical Trials

Combined Human Milk Oligosaccharides (HMOs) and Probiotics Intervention for Children With Autism

Not Applicable

Active, not recruiting

Conditions: Autism Spectrum Disorder
Anxiety
Neurodevelopmental Disorders

Interventions: Other: Placebo
Dietary Supplement: Experimental

First Posted Date: 2021-12-09

Last Posted Date: 2023-06-28

Lead Sponsor: The University of Queensland

Target Recruit Count: 60

Registration Number: NCT05151601

Locations: 🇦🇺
University of Queensland, Child Health Research Centre, Brisbane, Queensland, Australia

iToBoS: Clinical Data Acquisition Study

Not Applicable

Not yet recruiting

Conditions: Melanoma

Interventions: Device: The intelligent total body scanner (iToBoS)

First Posted Date: 2021-10-12

Last Posted Date: 2024-05-14

Lead Sponsor: The University of Queensland

Target Recruit Count: 600

Registration Number: NCT05075356

Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment

Not Applicable

Conditions: Anxiety
Cognitive Impairment
Psychotherapy

Interventions: Behavioral: Cognitive Behavioral Therapy (CBT)

First Posted Date: 2021-09-01

Last Posted Date: 2022-06-02

Lead Sponsor: The University of Queensland

Target Recruit Count: 26

Registration Number: NCT05030285

Locations: 🇦🇺
The University of Queensland, Brisbane, Queensland, Australia

PNEUmonia DOSing in Critically Ill Patients (PNEUDOS)

Conditions: Pneumonia

Interventions: Other: Blood sampling
Other: Epithelial lining fluid sampling
Other: Urine sampling
Drug: Study antibiotics include benzylpenicillin, ceftriaxone, meropenem, and piperacillin/tazobactam

First Posted Date: 2021-08-02

Last Posted Date: 2021-08-02

Lead Sponsor: The University of Queensland

Target Recruit Count: 80

Registration Number: NCT04986254

Locations: 🇦🇺
Royal Brisbane and Women's Hospital, Brisbane, Australia
🇲🇾
University of Malaya, Kuala Lumpur, Malaysia
🇦🇺
The Alfred, Melbourne, Australia

and more 3 locations

Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

Phase 3

Recruiting

Conditions: Autosomal Dominant Polycystic Kidney Disease

Interventions: Drug: Metformin XR
Other: Control

First Posted Date: 2021-06-25

Last Posted Date: 2025-05-08

Lead Sponsor: The University of Queensland

Target Recruit Count: 1174

Registration Number: NCT04939935

Locations: 🇦🇺
Renal Research, Gosford, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal North Shore Hospital, Sydney, New South Wales, Australia

and more 37 locations

INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)

Not Applicable

Recruiting

Conditions: Kidney Failure

Interventions: Other: Incremental HD
Other: Conventional HD

First Posted Date: 2021-06-18

Last Posted Date: 2024-04-18

Lead Sponsor: The University of Queensland

Target Recruit Count: 372

Registration Number: NCT04932148

Locations: 🇦🇺
Bundaberg Hospital, Bundaberg, Queensland, Australia
🇦🇺
Redland Hospital, Cleveland, Queensland, Australia
🇦🇺
Cairns Hospital, Cairns, Queensland, Australia

and more 13 locations

T2 and SeptiCyte RAPID Duration Project

Recruiting

Conditions: Bacteremia

First Posted Date: 2021-03-29

Last Posted Date: 2023-08-08

Lead Sponsor: The University of Queensland

Target Recruit Count: 100

Registration Number: NCT04821661

Locations: 🇦🇺
Caboolture Hospital, Brisbane, Queensland, Australia
🇦🇺
Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
🇦🇺
Redcliffe Hospital, Brisbane, Queensland, Australia

Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

Phase 2

Completed

Conditions: Motor Neuron Disease
Amyotrophic Lateral Sclerosis

Interventions: Drug: Trimetazidine Dihydrochloride

First Posted Date: 2021-03-09

Last Posted Date: 2023-07-20

Lead Sponsor: The University of Queensland

Target Recruit Count: 21

Registration Number: NCT04788745

Locations: 🇬🇧
King's College London, London, United Kingdom
🇦🇺
Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia
🇳🇱
University Medical Centre Utrecht, Utrecht, Netherlands

Mindfulness Meditation Versus Clinical Hypnosis for Acute, Experimental Pain

Phase 2

Completed

Conditions: Clinical Hypnosis
Mindfulness Meditation

Interventions: Behavioral: Clinical hypnosis
Behavioral: Mindfulness meditation

First Posted Date: 2021-03-08

Last Posted Date: 2023-12-04

Lead Sponsor: The University of Queensland

Target Recruit Count: 105

Registration Number: NCT04786405

Locations: 🇦🇺
The University of Queensland, Brisbane, Queensland, Australia

Food or Supplemental Lutein Absorption

Phase 1

Withdrawn

Conditions: Macula Lutea Opacity

Interventions: Other: Food, blended
Other: Food, unprocessed
Dietary Supplement: Lutein supplement

First Posted Date: 2021-03-08

Last Posted Date: 2021-07-12

Lead Sponsor: The University of Queensland

Registration Number: NCT04786392

Locations: 🇦🇺
School of Human Movement and Nutrition Sciences, The University of Queensland, Saint Lucia, Queensland, Australia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy